- -

Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Martínez-Férriz, Arantxa es_ES
dc.contributor.author Gandía, Carolina es_ES
dc.contributor.author Pardo-Sánchez, José Miguel es_ES
dc.contributor.author Fathinajafabadi, Alihamze es_ES
dc.contributor.author Ferrando Monleón, Alejandro Ramón es_ES
dc.contributor.author Farras, Rosa es_ES
dc.date.accessioned 2024-04-23T18:06:33Z
dc.date.available 2024-04-23T18:06:33Z
dc.date.issued 2023-03-13 es_ES
dc.identifier.uri http://hdl.handle.net/10251/203713
dc.description.abstract [EN] Background Eukaryotic Initiation Factor 5A (eIF-5A), an essential translation factor, is post-translationally activated by the polyamine spermidine. Two human genes encode eIF-5A, being eIF5-A1 constitutively expressed whereas eIF5-A2 is frequently found overexpressed in human tumours. The contribution of both isoforms with regard to cellular proliferation and invasion in non-small cell lung cancer remains to be characterized. Methods We have evaluated the use of eIF-5A2 gene as prognosis marker in lung adenocarcinoma (LUAD) patients and validated in immunocompromised mice. We have used cell migration and cell proliferation assays in LUAD lines after silencing each eIF-5A isoform to monitor their contribution to both phenotypes. Cytoskeleton alterations were analysed in the same cells by rhodamine-phalloidin staining and fluorescence microscopy. Polysome profiles were used to monitor the effect of eIF-5A2 overexpression on translation. Western blotting was used to study the levels of eIF-5A2 client proteins involved in migration upon TGFB1 stimulation. Finally, we have co-localized eIF-5A2 with puromycin to visualize the subcellular pattern of actively translating ribosomes. Results We describe the differential functions of both eIF-5A isoforms, to show that eIF5-A2 properties on cell proliferation and migration are coincident with its features as a poor prognosis marker. Silencing of eIF-5A2 leads to more dramatic consequences of cellular proliferation and migration compared to eIF-5A1. Overexpression of eIF5A2 leads to enhanced global translation. We also show that TGF ss signalling enhances the expression and activity of eIF-5A2 which promotes the translation of polyproline rich proteins involved in cytoskeleton and motility features as it is the case of Fibronectin, SNAI1, Ezrin and FHOD1. With the use of puromycin labelling we have co-localized active ribosomes with eIF-5A2 not only in cytosol but also in areas of cellular protrusion. We have shown the bulk invasive capacity of cells overexpressing eIF-5A2 in mice. Conclusions We propose the existence of a coordinated temporal and positional interaction between TFGB and eIF-5A2 pathways to promote cell migration in NSCLC. We suggest that the co-localization of actively translating ribosomes with hypusinated eIF-5A2 facilitates the translation of key proteins not only in the cytosol but also in areas of cellular protrusion. es_ES
dc.description.sponsorship This work was supported by: Fondo de Investigacion Sanitaria, ISCIII, grant number PI20-194, co-funded by ERDF/ESF, "Investing in your future". Ministerio de Educacion, Cultura y Deporte grant FPU13/02755 for JMPS. Asociacion Espanola contra el Cancer, AECC predoctoral grant for AMF. Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020). This article is based upon work from COST Action CA20113 ProteoCure, supported by COST (European Cooperation in Science and Technology). es_ES
dc.language Inglés es_ES
dc.publisher BioMed Central es_ES
dc.relation.ispartof Cell Communication and Signaling es_ES
dc.rights Reconocimiento (by) es_ES
dc.subject TGFB1 signaling es_ES
dc.subject Translating ribosomes es_ES
dc.subject Cytoskeleton organization es_ES
dc.subject Cell migration es_ES
dc.subject Lung adenocarcinoma es_ES
dc.title Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.1186/s12964-023-01076-6 es_ES
dc.relation.projectID info:eu-repo/grantAgreement/MECD//FPU13%2F02755/ES/FPU13%2F02755/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/FEDER//PI20-194//Investing in your future/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/COST//CA20113/ es_ES
dc.rights.accessRights Abierto es_ES
dc.description.bibliographicCitation Martínez-Férriz, A.; Gandía, C.; Pardo-Sánchez, JM.; Fathinajafabadi, A.; Ferrando Monleón, AR.; Farras, R. (2023). Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity. Cell Communication and Signaling. 21(1). https://doi.org/10.1186/s12964-023-01076-6 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion https://doi.org/10.1186/s12964-023-01076-6 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 21 es_ES
dc.description.issue 1 es_ES
dc.identifier.eissn 1478-811X es_ES
dc.identifier.pmid 36915194 es_ES
dc.identifier.pmcid PMC10009989 es_ES
dc.relation.pasarela S\513480 es_ES
dc.contributor.funder Generalitat Valenciana es_ES
dc.contributor.funder European Regional Development Fund es_ES
dc.contributor.funder Asociación Española Contra el Cáncer es_ES
dc.contributor.funder Ministerio de Educación, Cultura y Deporte es_ES
dc.contributor.funder European Cooperation in Science and Technology es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem